This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Moderna Inc. shed 7.5% to $49.56 on what proved to be an all-around grim trading session for the stock market, with the NASDAQ Composite Index falling 2.1% to 20,948.36 and Dow Jones Industrial Average falling 1.7% to 45,166.64.
The stock's fall snapped a three-day winning streak.
Moderna Inc. closed 16.8% short of its 52-week high of $59.55, which the company achieved on March 4th.
The stock underperformed when compared to some of its peers, as Johnson & Johnson rose 0.5% to $240.45, Pfizer Inc. fell 1.9% to $27.04, and Gilead Sciences Inc. fell 1.92% to $134.25.
Trading volume totaled 7.0 million, compared to the 50-day average of 11.1 million.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
March 27, 2026 16:32 ET (20:32 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.
Comments